GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Prism Biolab Co Ltd (TSE:206A) » Definitions » Days Payable

Prism Biolab Co (TSE:206A) Days Payable : 0.00 (As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Prism Biolab Co Days Payable?

Prism Biolab Co's average Accounts Payable for the six months ended in Sep. 2024 was 円0.0 Mil. Prism Biolab Co's Cost of Goods Sold for the six months ended in Sep. 2024 was 円100.0 Mil. Hence, Prism Biolab Co's Days Payable for the six months ended in Sep. 2024 was 0.00.

The historical rank and industry rank for Prism Biolab Co's Days Payable or its related term are showing as below:

TSE:206A's Days Payable is not ranked *
in the Biotechnology industry.
Industry Median: 125.06
* Ranked among companies with meaningful Days Payable only.

Prism Biolab Co's Days Payable stayed the same from Sep. 2023 (0.00) to Sep. 2024 (0.00).


Prism Biolab Co Days Payable Historical Data

The historical data trend for Prism Biolab Co's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prism Biolab Co Days Payable Chart

Prism Biolab Co Annual Data
Trend Sep22 Sep23 Sep24
Days Payable
- - -

Prism Biolab Co Semi-Annual Data
Sep22 Sep23 Mar24 Sep24
Days Payable - - - -

Competitive Comparison of Prism Biolab Co's Days Payable

For the Biotechnology subindustry, Prism Biolab Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Prism Biolab Co's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Prism Biolab Co's Days Payable distribution charts can be found below:

* The bar in red indicates where Prism Biolab Co's Days Payable falls into.



Prism Biolab Co Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Prism Biolab Co's Days Payable for the fiscal year that ended in Sep. 2024 is calculated as

Days Payable (A: Sep. 2024 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Sep. 2023 ) + Accounts Payable (A: Sep. 2024 )) / count ) / Cost of Goods Sold (A: Sep. 2024 )*Days in Period
=( (0 + 0) / 1 ) / 145.081*365
=0 / 145.081*365
=0.00

Prism Biolab Co's Days Payable for the quarter that ended in Sep. 2024 is calculated as:

Days Payable (Q: Sep. 2024 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Mar. 2024 ) + Accounts Payable (Q: Sep. 2024 )) / count ) / Cost of Goods Sold (Q: Sep. 2024 )*Days in Period
=( (0 + 0) / 1 ) / 99.99*365 / 2
=0 / 99.99*365 / 2
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Prism Biolab Co Days Payable Related Terms

Thank you for viewing the detailed overview of Prism Biolab Co's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Prism Biolab Co Business Description

Traded in Other Exchanges
N/A
Address
2-26-1 Muraokahigashi, Kanagawa, Fujisawa, JPN, 251-8555
Prism Biolab Co Ltd is engaged in drug discovery and development based on PepMetics Technology, a proprietary platform technology.

Prism Biolab Co Headlines

No Headlines